What is ANEB's earnings growth forecast for 2025-2025?
(NASDAQ: ANEB) Anebulo Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 29.44%.
Anebulo Pharmaceuticals's earnings in 2024 is -$9,347,314.
In 2025, ANEB is forecast to generate -$13,485,273 in earnings, with the lowest earnings forecast at -$13,485,273 and the highest earnings forecast at -$13,485,273.
What is ANEB's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: ANEB) forecast ROE is -270.5%, which is considered weak.
What is ANEB's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: ANEB) Anebulo Pharmaceuticals's current Earnings Per Share (EPS) is -$0.37. In 2025, ANEB's EPS is forecast to hit -$0.52 (min: -$0.52, max: -$0.52).
What is ANEB's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: ANEB) forecast ROA is -224.92%, which is lower than the forecast US Biotechnology industry average of 10.21%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.